Global Tyrosinase Market Strategic Research Report

Scope of the Report

The global Tyrosinase market size is predicted to grow from US$ 12.17 million in 2025 to US$ 18.54 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

Tyrosinase is a copper-containing oxidase widely considered the rate-limiting enzyme controlling melanin production. In the classic Raper-Mason pathway, it catalyzes the hydroxylation of tyrosine and the oxidation of dopa (DOPA) to form ortho-quinones, which then polymerize into melanin. This enzyme is also a key polyphenol oxidase in the enzymatic browning process of fruits and vegetables and is found in animals, plants, and various microorganisms.

In 2024, global Tyrosinase sales reached approximately 58 K Dose, with an average global market price of around 188.9 US$/Dose. Production capacity reached 70 K Dose, with a gross profit margin of approximately 40%.

Global Tyrosinase key players include Merck KGaA, Leica Biosystems, RayBiotech, BIO SB and Sinopharm Chemical Reagent, etc. Global top five manufacturers hold a share above 40%.

The largest market is Americas, has a share above 45%, followed by Asia Pacific and Europe, with around 20% and 30% market share respectively.

In terms of product, Fungus Extraction is the largest segment, with a share above 80%. And in terms of application, the largest application is Pharmaceuticals, accounting for about 75% of the market, followed by Cosmetics, etc.

Research in academia and pharmaceuticals on melanin production pathways, disease mechanisms such as melanoma and albinism continues to expand. Tyrosinase is considered a key target for melanin production and enzymatic browning, driving reliance on stable, highly active enzyme sources and standardized assay protocols in basic research and drug discovery. In cosmetics and dermatological applications, regulatory agencies and academia are increasingly concerned about the health risks of traditional skin-whitening ingredients. For example, Europe and parts of Asia have banned or strictly restricted the use of skin-whitening cosmetics containing hydroquinone. This has prompted the industry to shift towards safer, novel tyrosinase inhibitors, and the screening of these candidate molecules heavily relies on in vitro tyrosinase activity and inhibition assay platforms. Stricter regulations on in vitro diagnostic quality control, cosmetic safety evaluation, and food additive risk assessment have made standardized enzymological tools and validated antibody products crucial components of the compliant development process.

This report presents a comprehensive overview of the global Tyrosinase market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Fungus Extraction
• Bacterial Extraction
• Others

Segment by Physical Properties

• Powder
• Solution

Segment by Dose

• 25KU
• 100KU
• Others

Segment by Application

• Cosmetics
• Pharmaceuticals
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Tyrosinase market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Cosmetics, Pharmaceuticals, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact